Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site swelling
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (sore), ECZEMA (eczema), VACCINATION SITE PRURITUS (rash, little swollen, red, itching,  INJECTION SITE), VACCINATION SITE RASH (rash, little swollen, red, itching,  INJECTION SITE) and VACCINATION SITE ERYTHEMA (rash, little swollen, red, itching,  INJECTION SITE) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Seafood allergy (Hives, body swelling, coughing and tightening of throat muscles) since 01-Jan-1968, Hives, Hypersensitivity reaction and Hypertension since 01-Jan-1995. Concomitant products included ROSUVASTATIN from 01-Jan-2010 to an unknown date for High cholesterol, AMLODIPINE BESYLATE from 01-Jan-1997 to an unknown date, ATENOLOL from 01-Jan-1991 to an unknown date and TELMISARTAN (MICARDIS) from 01-Jan-2007 to an unknown date for Hypertension. On 09-Mar-2021 at 10:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN (sore). On 19-Mar-2021 at 5:00 AM, the patient experienced ECZEMA (eczema), VACCINATION SITE PRURITUS (rash, little swollen, red, itching,  INJECTION SITE), VACCINATION SITE RASH (rash, little swollen, red, itching,  INJECTION SITE), VACCINATION SITE ERYTHEMA (rash, little swollen, red, itching,  INJECTION SITE) and VACCINATION SITE SWELLING (rash, little swollen, red, itching,  INJECTION SITE). On 26-Mar-2021 at 5:00 AM, ECZEMA (eczema), VACCINATION SITE PRURITUS (rash, little swollen, red, itching,  INJECTION SITE), VACCINATION SITE RASH (rash, little swollen, red, itching,  INJECTION SITE), VACCINATION SITE ERYTHEMA (rash, little swollen, red, itching,  INJECTION SITE) and VACCINATION SITE SWELLING (rash, little swollen, red, itching,  INJECTION SITE) had resolved. At the time of the report, PAIN (sore) had resolved. Not Provided. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Magnetic resonance imaging: (Inconclusive) 3 days prior which the patient have had before with no problems. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment details included Tylenol and cold compresses. Concomitant medications also included supplements for unspecified indication. The patient  got a MRI without Iodine contrast (Allergic to shrimp) but with another contrast for a pre QX procedure before. Three days prior to adverse events caused by vaccine the patient had an MRI with contrast (which she had before with no problems).  The rash appeared only at the injection site and the contrast injection site.  At the vaccine site there was rash and itchiness.  At the contrast site just rash.  the patient spoke with her medical doctor and he recommended using cool compresses, which she did.  This helped.  The reaction to the vaccine lasted approximately 7 to 10 days. Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Patients demographics, race, ethnicity, concomitant medications and there start and stop date with ongoing status along with the dosage details and indication, 2nd dose details, de-re-challenge, adverse event start and stop date, case narrative were updated.